3.62

3.21% -0.12

After Hours: 3.59 -0.03 -0.83%

Ironwood Pharmaceuticals Inc (IRWD)

Overview News Price History Option Chain Financials Discussions Forecast

Ironwood Pharmaceuticals Inc stock is traded at $3.62, with a volume of 2.12M. It is down -3.21% in the last 24 hours and down -18.65% over the past month. Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Previous Close:

$3.74

Open:

$3.68

24h Volume:

2.12M

Relative Volume:

0.50

Market Cap:

$590.27M

Revenue:

$400.57M

Net Income/Loss:

$9.21M

P/E Ratio:

90.50

EPS:

0.04

Net Cash Flow:

$146.36M

1W Performance:

-1.09%

1M Performance:

-18.65%

6M Performance:

+213.42%

1Y Performance:

+135.06%

1-Day Range:

$3.56

$3.82

1-Week Range:

$3.22

$3.82

52-Week Range:

$0.5271

$5.78

Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile

Name

Ironwood Pharmaceuticals Inc

Sector

Healthcare (1108)

Industry

Drug Manufacturers - Specialty & Generic (83)

Phone

617-621-7722

Address

100 SUMMER STREET, SUITE 2300, BOSTON, MA

Employee

253

Twitter

@ironwoodpharma

Next Earnings Date

2025-02-21

Latest SEC Filings

IRWD's Discussions on Twitter

Compare IRWD vs TAK, ZTS, HLN, TEVA, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IRWD Ironwood Pharmaceuticals Inc	3.62	609.84M	400.57M	9.21M	146.36M	0.04
TAK Takeda Pharmaceutical Co Adr	17.76	57.56B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	122.23	53.17B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	10.33	46.62B	14.54B	2.22B	2.58B	0.4879
TEVA Teva Pharmaceutical Industries Ltd Adr	31.75	38.33B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	485.06	21.48B	3.13B	1.27B	1.12B	26.39

Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-05-26	Upgrade	Citizens JMP	Mkt Perform → Mkt Outperform
Apr-15-25	Downgrade	Jefferies	Buy → Hold
Apr-15-25	Downgrade	Wells Fargo	Overweight → Equal Weight
Apr-14-25	Downgrade	Citizens JMP	Mkt Outperform → Mkt Perform
Sep-09-24	Initiated	Leerink Partners	Market Perform
Aug-08-24	Downgrade	CapitalOne	Overweight → Equal Weight
Jan-17-24	Initiated	Craig Hallum	Buy
Dec-14-23	Initiated	Wells Fargo	Overweight
Nov-09-23	Initiated	Jefferies	Buy
Sep-28-23	Initiated	JMP Securities	Mkt Outperform
Sep-02-22	Initiated	CapitalOne	Overweight
Apr-22-22	Initiated	Piper Sandler	Overweight
Sep-30-20	Downgrade	Wells Fargo	Overweight → Equal Weight
Jun-17-20	Initiated	Northland Capital	Outperform
Jul-10-19	Resumed	Credit Suisse	Neutral
Mar-27-19	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Feb-25-19	Upgrade	H.C. Wainwright	Sell → Neutral
Jan-24-19	Upgrade	JP Morgan	Underweight → Neutral
Nov-07-18	Downgrade	Credit Suisse	Outperform → Neutral
Nov-07-18	Downgrade	JP Morgan	Neutral → Underweight
Jul-23-18	Initiated	H.C. Wainwright	Sell
May-09-18	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Jan-05-18	Downgrade	BofA/Merrill	Buy → Underperform
Dec-06-17	Downgrade	Mizuho	Buy → Neutral
Jul-21-17	Downgrade	JP Morgan	Overweight → Neutral
May-03-17	Initiated	Wells Fargo	Outperform
Apr-07-17	Reiterated	Mizuho	Buy
Feb-22-17	Reiterated	Barclays	Equal Weight
Nov-04-16	Reiterated	Mizuho	Buy
Oct-24-16	Reiterated	Wedbush	Neutral
Oct-10-16	Reiterated	Mizuho	Buy
Sep-27-16	Reiterated	WallachBeth	Hold

View All

Ironwood Pharmaceuticals Inc Stock (IRWD) Latest News

Mar 04, 2026

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference - itemonline.com

Mar 04, 2026

US Stocks Recap: Does Ironwood Pharmaceuticals Inc have declining or rising EPSJuly 2025 Catalysts & Risk Controlled Daily Trade Plans - baoquankhu1.vn

Mar 04, 2026

Mar 02, 2026

Gains Report: Can Ironwood Pharmaceuticals Inc stock double in the next yearPrice Action & Target Return Focused Stock Picks - baoquankhu1.vn

Mar 02, 2026

IRWD Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Mar 02, 2026

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Mar 02, 2026